Spatial Metabolomics-Based Integrated Analysis Provides Evidence for the Mechanism of Salvianolic Acid A-Induced Mitochondrial Apoptosis in Non-Small Cell Lung Cancer via the ROS-Dependent Caspase Pathway
- 1College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- 2School of Information and Software Engineering, University of Electronic Science and Technology of China, Chengdu 611731, China
Abstract
Salvianolic acid A (SAA) exhibits antitumor activity against non-small cell lung cancer (NSCLC), but the metabolic regulatory mechanisms underlying its effects remain incompletely understood. In this study, we integrated desorption electrospray ionization mass spectrometry imaging (DESI-MSI), network pharmacology, molecular docking, and functional validation to investigate the effects of SAA on NSCLC. SAA inhibited H1299 cell viability, migration, and invasion and induced apoptosis. DESI-MSI analysis of xenograft tumor tissues revealed marked metabolic alterations after SAA treatment, including changes in ceramides, glycerophospholipids, and arachidonic acid candidates. Network pharmacology and molecular docking further suggested the involvement of oxidative stress- and apoptosis-related pathways. Functionally, SAA increased intracellular ROS levels, impaired mitochondrial function, and reduced mitochondrial membrane potential. Treatment with the ROS scavenger NAC partially reversed SAA-induced ROS accumulation, loss of cell viability, and increased levels of cleaved Caspase-9 and Caspase-3. Consistently, Western blotting and immunofluorescence analyses showed concentration-dependent activation of Caspase-9 and Caspase-3, whereas the pan-caspase inhibitor Z-VAD-FMK significantly attenuated SAA-induced cell death and apoptosis. Collectively, these findings provide evidence that SAA induces metabolic remodeling and promotes ROS-associated mitochondrial dysfunction and caspase-mediated apoptosis in NSCLC, thereby suggesting a potential metabolic mechanism underlying its antitumor activity.
Related
- Mechanism of luteolin in treating chronic heart failure by regulating HIF-1 signaling pathway-mediated mitochondrial damage to inhibit cardiomyocyte apoptosis
- PACE4 Regulates Apoptosis in Human Prostate Cancer Cells via Endoplasmic Reticulum Stress and Mitochondrial Signaling Pathways [Retraction].
- Inhibitory Mechanism of Bee Venom Against A431 Cutaneous Squamous Cell Carcinoma Cells Based on Label-Free Proteomics and Untargeted Metabolomics
- Discovery of metabolite biomarkers for cerebral ischemia-reperfusion injury based on metabolomics: neurotoxic mechanism and functional validation of a flavopiridol -related metabolite
- Integrated Spatial Metabolomics and Proteomics from the Same Tissue Section Using a Conductive ITO-PET Slide
BibTeX
@article{jiang2026spatial,
title = {{Spatial Metabolomics-Based Integrated Analysis Provides Evidence for the Mechanism of Salvianolic Acid A-Induced Mitochondrial Apoptosis in Non-Small Cell Lung Cancer via the ROS-Dependent Caspase Pathway}},
author = {Ruyu Jiang and Hairong Xiang and Lushuang Xie and Linfeng Zhao and Dawei Zeng and Yue Zhang and Jiazhen Xie and Zhenxu Pan and Yanju Gong and Lan Yang},
journal = {Biomolecules},
year = {2026},
month = oct,
doi = {10.3390/biom16101434},
url = {https://www.mdpi.com/2218-273X/16/10/1434},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Spatial Metabolomics-Based Integrated Analysis Provides Evidence for the Mechanism of Salvianolic Acid A-Induced Mitochondrial Apoptosis in Non-Small Cell Lung Cancer via the ROS-Dependent Caspase Pathway
AU - Ruyu Jiang
AU - Hairong Xiang
AU - Lushuang Xie
AU - Linfeng Zhao
AU - Dawei Zeng
AU - Yue Zhang
AU - Jiazhen Xie
AU - Zhenxu Pan
AU - Yanju Gong
AU - Lan Yang
PY - 2026
DA - 2026/10/01
JO - Biomolecules
DO - 10.3390/biom16101434
UR - https://www.mdpi.com/2218-273X/16/10/1434
AB - Salvianolic acid A (SAA) exhibits antitumor activity against non-small cell lung cancer (NSCLC), but the metabolic regulatory mechanisms underlying its effects remain incompletely understood. In this study, we integrated desorption electrospray ionization mass spectrometry imaging (DESI-MSI), network pharmacology, molecular docking, and functional validation to investigate the effects of SAA on NSCLC. SAA inhibited H1299 cell viability, migration, and invasion and induced apoptosis. DESI-MSI analysis of xenograft tumor tissues revealed marked metabolic alterations after SAA treatment, including changes in ceramides, glycerophospholipids, and arachidonic acid candidates. Network pharmacology and molecular docking further suggested the involvement of oxidative stress- and apoptosis-related pathways. Functionally, SAA increased intracellular ROS levels, impaired mitochondrial function, and reduced mitochondrial membrane potential. Treatment with the ROS scavenger NAC partially reversed SAA-induced ROS accumulation, loss of cell viability, and increased levels of cleaved Caspase-9 and Caspase-3. Consistently, Western blotting and immunofluorescence analyses showed concentration-dependent activation of Caspase-9 and Caspase-3, whereas the pan-caspase inhibitor Z-VAD-FMK significantly attenuated SAA-induced cell death and apoptosis. Collectively, these findings provide evidence that SAA induces metabolic remodeling and promotes ROS-associated mitochondrial dysfunction and caspase-mediated apoptosis in NSCLC, thereby suggesting a potential metabolic mechanism underlying its antitumor activity.
SN - 2218-273X
ER -